InsidersTradesSigma
HLB바이오스텝: directors' dealings · South Korea · DART (FSS)
DART:hlb-0f3bfaKR·DART (FSS)Mcap 80.8Bn€Healthcare
Explore the full management transaction log of HLB바이오스텝, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, HLB바이오스텝 has logged 20 insider filings. Market capitalisation: €80.8bn. The latest transaction was disclosed on 11 May 2026 — Sale. Among the most active insiders: HLB. The full history is accessible without an account.
20
Insider Decl.
0
Thresholds
€1m
9 ops.
Buy Volume
€39m
10 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
4785.00 €
Analyst consensus
Income statement
Revenue74.05 Bn€
Gross profit56.43 Bn€76% margin
Net income−18.96 Bn€-25.6% margin
Valuation
Beta-0.00
Balance sheet & cash
Market cap80.84 Bn€
Total debt30.76 Bn€
Free Cash Flow1.03 Bn€
Debt / Equity30%
Profitability & ownership
ROE-18.6%
ROA-3.3%
% insiders16.9%
% institutions0.5%
Last declaration on 11 May 2026
Declarations0 total
No declarations found
0 of 0 declarations